Suit Says Abbott Conspired To Block Generic TriCor

Law360, New York (March 18, 2008, 12:00 AM EDT) -- Eighteen states and the District of Columbia have filed a lawsuit alleging that Abbott Laboratories and Fournier Industrie et Sante conspired to delay and prevent a generic version of their TriCor cholesterol drug from reaching the market by filing a series of frivolous patent infringement lawsuits.

The suit, which was filed Tuesday in the U.S. District Court for the District of Delaware, says that Abbott and its French partner brought a series of groundless patent lawsuits against generics companies, citing patents the two companies had obtained...
To view the full article, register now.